Skip to main content

Advertisement

Log in

Early diagnosis and treatment of pancreas allograft rejection

  • Original Articles
  • Published:
Transplant International

Abstract

A major problem in vascularized pancreas transplantation is the lack of reliable methods for the early diagnosis and effective treatment of allograft rejection. Over a 2-year period, 54 rejection episodes occurred in 31 patients (13 isolated pancreas, 18 simultaneous pancreas-kidney recipients) with pancreaticoduodenocystostomy. A total of 253 radionuclide pancreas examinations were performed (mean 8.4 per patient) utilizing 99mtechnetium-DTPA. Computer analysis generated a quantitative measure of blood flow to the allograft caused the technetium index (TI). Rejection episodes were characterized as isolated pancreas (22), combined pancreas-kidney (16), or isolated renal (16) allograft rejection in combined engraftments. The majority of rejection episodes occurred early (within 3 months of transplant, N=47) and were more responsive than late rejection to anti-rejection therapy (89.4% vs 42.9%, P=0.01). Mean urinary amylase (UA) levels and TI during normal allograft function were 29,398 U/l and 0.55%, while levels heralding rejection were 6,528 U/l and 0.40%, respectively (P<0.05). The treatment of rejection based upon renal dysfunction or combined renal and pancreas dysfunction resulted in significantly higher graft salvage with a lower incidence of hyperglycemia when compared to isolated pancreas allograft rejection. Of the 11 patients who developed hyperglycemia, 8 (72.7%) ultimately lost their pancreas grafts (P<0.001). Following therapy, a TI above 0.3% was associated with 97.4% graft survival, while levels below 0.3% resulted in a 70% rate of graft loss (P<0.001). Similarly, pancreas allografts with a UA above 10,000 U/l had 91.1% functional survival, while levels below 10,000 U/l resulted in a 66.7% rate of graft loss (P<0.001). Overall, reversal of rejection occurred in 83.3% of cases, with 9 grafts lost due to rejection at a mean of 4.7 months post-transplant. Therapy with ALG or OKT3 was more effective in reversing allograft rejection than pulsed corticosteroids alone (68.8% vs 47.9%, P=0.05). Patient and pancreas allograft survival is 96.8% and 67.7%, respectively, after a mean follow-up interval of 14.9 months. Monitoring pancreas allograft function by UA, TI, and renal function (in simultaneous transplants) allows for the timely diagnosis and successful treatment of pancreas allograft rejection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baumgartner D, Largiadèr F, Uhlschmid G, Binswanger U (1983) Rejection episodes in recipients of simultaneous pancreas and kidney transplants. Transplant Proc 15: 1330–1331

    Google Scholar 

  2. Borgstrom A, Marks WH, Dafoe DC, Campbell DA Jr, Turcotte JG (1986) Immunoreactive anionic and cationic trypsins in serum after experimental porcine pancreatic transplantation. Surgery 100: 841–849

    Google Scholar 

  3. Corry RJ, Nghiem DD, Schulak JA, Beutel WD, Gonwa TA (1986) Surgical treatment of diabetic nephropathy with simultaneous pancreatic, duodenal and renal transplantation. Surg Gynecol Obstet 162: 547–555

    Google Scholar 

  4. Crass JR, Feinberg SB, Sutherland DER, Loken M, Gedgaudas EG (1982) Radiology of the human segmental pancreatic transplant. Gastrointest Radiol 7: 153–158

    Google Scholar 

  5. Dubernard JM, Traeger J, Touraine JL, Betuel H, Malik MC (1980) Rejection of human pancreatic allografts. Transplant Proc 12: 103–106

    Google Scholar 

  6. Florack G, Sutherland DER, Sibley RK, Najarian JS, Squifflet JP (1985) Combined kidney and segmental pancreas allotransplantation in dogs. Transplant Proc 17: 374–377

    Google Scholar 

  7. Gotoh M, Monden M, Motoki Y, Sakane O, Shima K, Okamura J (1984) Early detection of rejection in the allografted pancreas. Transplant Proc 16: 781–782

    Google Scholar 

  8. Groth CG, Lundgren G, Arner P, Cellste H, Hardstedt C, Lewander R, Ostman J (1976) Rejection of isolated pancreatic allografts in patients with diabetes. Surg Gynecol Obstet 143: 933–940

    Google Scholar 

  9. Grundfest-Bronitowski S, Novick A (1986) Pancreas transplantation — 1985. Transplant Proc [Suppl 2] 18: 31–39

    Google Scholar 

  10. Hahn D, Bull U, Land W (1983) Pancreatic grafts-nuclear perfusion imaging to detect vascular complications and rejection crises. Horm Metab Res [Suppl] 13: 78

    Google Scholar 

  11. Jamieson NV, McMaster P, Wraight EP, Evans DB, Calne RY (1980) Radionuclide imaging in pancreatic transplantation. Nucl Med Commun 1: 291

    Google Scholar 

  12. Land W, Illner WD, Abendroth D, Landgraf R (1984) Experience with 13 segmental pancreas transplants in cyclosporine-treated diabetic patients using ethibloc for duct obliteration (surgical aspects). Transplant Proc 16: 729–732

    Google Scholar 

  13. Munda R, Tom WW, First MR, Gartsid P, Alexander JW (1987) Pancreatic allograft exocrine urinary tract diversion: pathophysiology. Transplantation 43: 95–99

    Google Scholar 

  14. Nghiem DD, Gonwa TA, Corry RJ (1987) Metabolic effects of urinary diversion of exocrine secretions in pancreatic transplantation. Transplantation 43: 70–73

    Google Scholar 

  15. Perlman SB, Deierhoi MH, Wilson MA, Rowe B, Sollinger HW (1986) Noninvasive evaluation of pancreas allografts. J Nucl Med 27: 909

    Google Scholar 

  16. Powell CS, Lindsey NJ, Nolan MS, Wiley KN, Boyle PF, Harold A (1987) The value of urinary amylase as a marker of early pancreatic allograft rejection. Transplantation 43: 921–923

    Google Scholar 

  17. Prieto M, Sutherland DER, Fernández-Cruz L, Heil J, Najarian JS (1987) Experimental and clinical experience with urine amylase monitoring for early diagnosis of rejection in pancreas transplantation. Transplantation 43: 73–79

    Google Scholar 

  18. Schroeder TJ, Weiskittel P, Bailey D, Melvin DB, Munda R, Clardy CW, Balisteri WF, Penn I, Fidler JP, Alexander JW, First MR (1988) Clinical efficacy and side effects of Orthoclone OKT3 in renal, pancreatic, hepatic, and cardiac transplantation. Transplantation (in press)

  19. Schulak JA, Drevyanko TF (1985) Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of anti-rejection therapy. Surgery 98: 330–336

    Google Scholar 

  20. Sibley RK, Mukai K (1983) Pathological features in 29 segmental pancreas transplants in 27 patients. Lab Invest 48: 78a

  21. Simeone JF, Wittenberg J, Ferrucci JT (1980) Modern concepts of imaging of the pancreas. Invest Radiol 15: 6

    Google Scholar 

  22. Sollinger HW, Cook K, Kamps D, Glass NR, Belzer FO (1984) Clinical and experimental experience with pancreaticocystostomy for exocrine pancreatic drainage in pancreas transplantation. Transplant Proc 16: 741–751

    Google Scholar 

  23. Sollinger HW, Stratta RJ, Kalayoglu M, Pirsch JD, Belzer FO (1987) Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression. Surgery 102: 674–679

    Google Scholar 

  24. Starzl TE, Iwatsuki S, Shaw BW, Greene DA, Van Thiel DH, Nalesnik MA, Nusbacher J, Diliz-Pere H, Hakala TR (1984) Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 159: 265–272

    Google Scholar 

  25. Sutherland DER, Moudry KC (1987) Pancreas transplant registry report — 1986. Clin Transplant 1: 3–17

    Google Scholar 

  26. Sutherland DER, Goetz FC, Najarian JS (1984) One hundred pancreas transplants at a single institution. Ann Surg 200: 414–440

    Google Scholar 

  27. Sutherland DER, Goetz FC, Kendall DM, Najarian JS (1985) One institution's experience with pancreas transplantation. West J Med 143: 838–844

    Google Scholar 

  28. Thistlethwaite JR Jr, Cosimi AB, Delmonico FL, Rubin RH, Tolkoff-Rubin N, Nelson PW, Fang L, Russell PS (1984) Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation 38: 695–701

    Google Scholar 

  29. Thomas F, Bogey W, Castellani W, Khazanie P, Tysor M, Thomas J (1988) Diagnosis of pancreatic allograft rejection by measurement of urinary radioimmunoreactive insulin. Transplantation (in press)

  30. Traeber J, Dubernard JM, Piatti PM, Bosie E, Gebet A, ElYafi S, Betuel H, Secchi A, Touraine JL, Pozza G (1984) Clinical aspects of pancreatic rejection in pancreatic and pancreaticorenal allotransplants. Transplant Proc 16: 718–719

    Google Scholar 

  31. Tyden G, Lundgren G, Gunnarsson R, Ostman J, Groth CG (1984) Laboratory findings during rejection of segmental pancreatic allografts. Transplant Proc 16: 715–717

    Google Scholar 

  32. Tyden G, Lundgren G, Ost L, Gunnarsson R, Ostman J, Groth CG (1986) Are pancreatic grafts prone to rejection? Transplant Proc 17: 27–29

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Stratta, R.J., Sollinger, H.W., Perlman, S.B. et al. Early diagnosis and treatment of pancreas allograft rejection. Transplant Int 1, 6–12 (1988). https://doi.org/10.1007/BF00337842

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00337842

Key words

Navigation